1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. ADAPTIMMUNE THERAPEUTICS PLC - ADR

Adaptimmune Therapeutics Plc - ADR

XNAS: ADAP

Weak Stock
Download real time

0.26 -0.01 (-3.70%)

82.43% Fall from 52W High

132.8K XNAS Volume

XNAS 23 May, 2025 11:23 AM (EDT)

Watchlist

Portfolio

Share
8S
15W
0O
3T
68.9

Market Cap

Below industry Median
-1

PE TTM

Negative PE TTM
0

PEG TTM

5.8

Price to Book

-0.7

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Adaptimmune Therapeutics Plc - ADR is on 29 May 2025 for the purpose of Adaptimmune Therapeutics PLC Annual General Meeting for 2025 See details

Adaptimmune Therapeutics Plc - ADR - ADAP - stock price prediction, stock price target, analyst ratings from 9 analysts

Adaptimmune Therapeutics Plc - ADR has a share price target of US$ 2, revenue growth forecast of -72.1%, and profit growth estimate of -90.7% for FY25, based on top 9 analyst calls.

Forecaster Screeners